Trans1 merger with spinal specialist Baxano helps straighten out finances
This article was originally published in Clinica
Executive Summary
Trans1 is acquiring Baxano, a fellow spinal technologies specialist, in a $23.6 million deal that will not only expand the former's product portfolio but give its finances a much needed boost.